Cftr Trikafta denied for missing prior authorization by CVS Caremark?
If the original prescription wasn't run through prior auth, the path is to submit a PA now with a medical-necessity letter — many plans then back-date approval to the date of service.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What CVS Caremark typically requires
Trikafta covered for FDA-labeled mutations + CF center attestation. Symdeko/Orkambi non-preferred when Trikafta-eligible.
What works in the appeal
CFF 2023 Modulator Recommendations + CFTR2 database for non-F508del responsive variants. April 2023 FDA expansion to age 2-5 (VX20-445-111). Step-therapy through inferior modulator contradicts CFF first-line Trikafta recommendation.
The CVS Caremark angle on Cftr Trikafta
## Why CVS Caremark Requires Prior Authorization for Trikafta
Trikafta (elexacaftor/tezacaftor/ivacaftor) is a high-cost specialty medication for cystic fibrosis. CVS Caremark places it on a specialty tier that uniformly requires prior authorization (PA) before the plan will cover a fill. A denial for "prior auth required" typically means either no PA was submitted, a PA was submitted but deemed incomplete, or a previously approved PA has expired. This is not a clinical rejection — it is an administrative gate that can be resolved with the right submission.
## Why It Is Appealable
Federal and state law require that PA criteria be applied consistently and that any adverse determination be subject to appeal. If the PA was submitted and denied on clinical grounds, that clinical determination is fully appealable. If the denial is purely administrative (no PA on file), work with your prescriber to submit the PA immediately and request a retrospective review if you have already paid out of pocket.
## Federal Appeal Framework
- Internal appeal (Level 1): File within the deadline on your EOB — typically 180 days from denial. CVS Caremark must respond within 30 days (pre-service, non-urgent) or 72 hours (urgent/expedited).
- Concurrent review: If you are mid-course on a fill that was previously covered, request a concurrent or continuation-of-care review.
- External review (ACA §2719 / ERISA §503): After exhausting internal appeals, you have approximately 4 months to request IRO review. Expedited external review is available when delay would seriously jeopardize health.
## Documentation to Gather
1. Certified CFTR genotype report — confirms your mutation falls within the FDA-approved indication; obtain from a CLIA-certified lab. 2. CF diagnosis records — pulmonologist or CF center notes documenting diagnosis, current lung function trajectory, and clinical status. 3. Prior-treatment history — records with dates and outcomes for any previous CF therapies, particularly any earlier CFTR modulators. 4. Prescriber medical-necessity letter — your CF specialist should document why Trikafta is the appropriate therapy for your mutation class and clinical picture, referencing the FDA-approved prescribing label and applicable CF Foundation treatment guidelines. 5. CVS Caremark PA criteria — download the current PA/coverage policy from CVS Caremark's provider or member portal and map every listed requirement to a specific document in your chart.
## Criteria-Mapping Structure
| CVS Caremark PA Requirement | Supporting Document | |---|---| | Confirmed CF diagnosis | Clinic note, [provider], [date] | | CFTR mutation within approved indication | Lab report, [lab name], [date] | | Prescriber is CF specialist or pulmonologist | Prescriber NPI and specialty on file | | Any step-therapy requirements satisfied | Prior-treatment records with dates/outcomes |
Request a copy of the specific PA criteria from CVS Caremark before writing your appeal so you can address each criterion explicitly.
## Practical Tip
If your prescriber's office submitted the PA but received no response within the regulatory timeframe, that "deemed denial" is itself appealable. Document the submission date and any confirmation numbers, and raise the timeline lapse in your appeal letter.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →